FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Piero Musiani

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Anatomy

Procedures

Genes & Molecular Sequences

Genes, erbB-2

Physiology

Transfection

Co-author Network

Publications

TOP 3
Manuela Iezzi; Piero Musiani; Elena Quaglino; F Sabatini; V Toto; Paola Cappello; C Curcio; G Garotta; Federica Cavallo
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice.
Graziella Berta; Susanna Cappia; Federica Di Scipio; Guido Forni; Manuela Iezzi; Barbara Mognetti; Piero Musiani; Mauro Papotti; Paolina Salamone; Michela Spadaro; Andrea E Sprio; Federica Cavallo
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters.
Carlo Sorrentino; Piero Musiani; Paolo Pompa; Giuseppe Cipollone; Emma Di Carlo
Androgen deprivation boosts prostatic infiltration of cytotoxic and regulatory T lymphocytes and has no effect on disease-free survival in prostate cancer patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Piero Musiani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Manuela Iezzi; Piero Musiani; Elena Quaglino; F Sabatini; V Toto; Paola Cappello; C Curcio; G Garotta; Federica Cavallo
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice.
International journal of immunopathology and pharmacology 2011;24(3):621-30.
2011: Graziella Berta; Susanna Cappia; Federica Di Scipio; Guido Forni; Manuela Iezzi; Barbara Mognetti; Piero Musiani; Mauro Papotti; Paolina Salamone; Michela Spadaro; Andrea E Sprio; Federica Cavallo
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters.
Cancer prevention research (Philadelphia, Pa.) 2011;4(7):994-1001.
2011: Carlo Sorrentino; Piero Musiani; Paolo Pompa; Giuseppe Cipollone; Emma Di Carlo
Androgen deprivation boosts prostatic infiltration of cytotoxic and regulatory T lymphocytes and has no effect on disease-free survival in prostate cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(6):1571-81.
2010: Marta Coscia; Elena Quaglino; Manuela Iezzi; Claudia Curcio; Francesca Pantaleoni; Chiara Riganti; Ingunn Holen; Hannu Mönkkönen; Mario Boccadoro; Guido Forni; Piero Musiani; Amalia Bosia; Federica Cavallo; Massimo Massaia
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.
Journal of cellular and molecular medicine 2010;14(12):2803-15.
2010: Aldo V Bono; Tania Pannellini; Marcella Liberatore; Rodolfo Montironi; Sergio Cosciani Cunico; Liang Cheng; Francesco Sasso; Piero Musiani; Manuela Iezzi
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2010;32(3):136-45.
2010: Simona Rolla; Francesco Ria; Sergio Occhipinti; Gabriele Di Sante; Manuela Iezzi; Michela Spadaro; Chiara Nicolò; Elena Ambrosino; Irene Fiore Merighi; Piero Musiani; Guido Forni; Federica Cavallo
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(11):6124-32.
2010: Isaia Barbieri; Sara Pensa; Tania Pannellini; Elena Quaglino; Diego Maritano; Marco Demaria; Alessandra Voster; James Turkson; Federica Cavallo; Christine J Watson; Paolo Provero; Piero Musiani; Valeria Poli
Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten.
Cancer research 2010;70(6):2558-67.
2010: Stefano Ugel; Elisa Scarselli; Manuela Iezzi; Carmela Mennuni; Tania Pannellini; Francesco Calvaruso; Barbara Cipriani; Raffaele De Palma; Lucia Ricci-Vitiani; Elisa Peranzoni; Piero Musiani; Paola Zanovello; Vincenzo Bronte
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes.
Blood 2010;115(7):1374-84.
2010: Isaia Barbieri; Elena Quaglino; Diego Maritano; Tania Pannellini; LUDOVICA RIERA; Federica Cavallo; Guido Forni; Piero Musiani; Roberto Chiarle; Valeria Poli
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene.
Molecular carcinogenesis 2010;49(2):114-20.
2010: Ida Casorelli; Tania Pannellini; Gabriele De Luca; Paolo Degan; Federica Chiera; IVANO IAVARONE; Alessandro Giuliani; Alessia Butera; Monica Boirivant; Piero Musiani; Margherita Bignami
The Mutyh base excision repair gene influences the inflammatory response in a mouse model of ulcerative colitis.
PloS one 2010;5(8):e12070.
2009: Maria Teresa Russo; Gabriele De Luca; Ida Casorelli; Paolo Degan; Sara Molatore; Flavia Barone; Filomena Mazzei; Tania Pannellini; Piero Musiani; Margherita Bignami
Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis.
Cancer research 2009;69(10):4372-9.
2009: Carla De Giovanni; Giordano Nicoletti; Arianna Palladini; Stefania Croci; Lorena Landuzzi; A Antognoli; A Murgo; Annalisa Astolfi; Silvano Ferrini; M Fabbi; Anna Maria Orengo; Augusto Amici; M L Penichet; L Aurisicchio; Manuela Iezzi; Piero Musiani; Patrizia Nanni; Pier-Luigi Lollini
A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome.
Human gene therapy 2009;20(5):453-64.
2009: Carla De Giovanni; Giordano Nicoletti; Lorena Landuzzi; Stefania Croci; Arianna Palladini; Agnese Antognoli; Annalisa Murgo; Marianna L Ianzano; Valentina Grosso; Valeria Stivani; Manuela Iezzi; Piero Musiani; Patrizia Nanni; Pier-Luigi Lollini
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.
Vaccine 2009;27(14):2065-9.
2008: Cristina Mastini; Pablo Daniel Becker; Manuela Iezzi; Claudia Curcio; Piero Musiani; Guido Forni; Federica Cavallo; Carlos A Guzmán
Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice.
Current cancer drug targets 2008;8(3):230-42.
2008: Elisa Ciraolo; Manuela Iezzi; Romina Marone; Stefano Marengo; Claudia Curcio; Carlotta Costa; Ornella Azzolino; Cristiano Gonella; Cristina Rubinetto; Haiyan Wu; Walter Dastrù; Erica L Martin; Lorenzo Silengo; Fiorella Altruda; Emilia Turco; Letizia Lanzetti; Piero Musiani; Thomas Rückle; Christian Rommel; Jonathan M Backer; Guido Forni; Matthias P Wymann; Emilio Hirsch
Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development.
Science signaling 2008;1(36):ra3.
2007: Patrizia Nanni; Giordano Nicoletti; Arianna Palladini; Stefania Croci; Annalisa Murgo; Agnese Antognoli; Lorena Landuzzi; Marina Fabbi; Silvano Ferrini; Piero Musiani; Manuela Iezzi; Carla De Giovanni; Pier-Luigi Lollini
Antimetastatic activity of a preventive cancer vaccine.
Cancer research 2007;67(22):11037-44.
2007: Carla De Giovanni; Stefania Croci; Giordano Nicoletti; Lorena Landuzzi; Arianna Palladini; Tania Pannellini; Ludovica Borgia; Manuela Iezzi; Emma Di Carlo; Anna Maria Orengo; Ronald C Kennedy; Pier-Luigi Lollini; Patrizia Nanni; Piero Musiani
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis.
International journal of cancer. Journal international du cancer 2007;121(1):88-94.
2007: Claudia Curcio; Tania Pannellini; Stefania Lanzardo; Guido Forni; Piero Musiani; Inés M Antón
WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome.
The Journal of pathology 2007;211(1):67-75.
2006: Claudia Chiodoni; Manuela Iezzi; Cristiana Guiducci; Sabina Sangaletti; Isabella Alessandrini; Chiara Ratti; Francesca Tiboni; Piero Musiani; D Neil Granger; Mario P Colombo
Triggering CD40 on endothelial cells contributes to tumor growth.
The Journal of experimental medicine 2006;203(11):2441-50.
2006: Elena Ambrosino; Michela Spadaro; Manuela Iezzi; Claudia Curcio; Guido Forni; Piero Musiani; Wei-Zen Wei; Federica Cavallo
Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance.
Cancer research 2006;66(15):7734-40.
2006: Tania Pannellini; Michela Spadaro; Emma Di Carlo; Elena Ambrosino; Manuela Iezzi; Augusto Amici; Pier-Luigi Lollini; Guido Forni; Federica Cavallo; Piero Musiani
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(12):7695-703.
2006: Lars Holmgren; Elena Ambrosino; Olivier Birot; Carl Tullus; Niina Veitonmäki; Tetyana Levchenko; Lena-Maria Carlson; Piero Musiani; Manuela Iezzi; Claudia Curcio; Guido Forni; Federica Cavallo; Rolf Kiessling
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(24):9208-13.
2005: Annalisa Astolfi; Simona Rolla; Patrizia Nanni; Elena Quaglino; Carla De Giovanni; Manuela Iezzi; Piero Musiani; Guido Forni; Pier-Luigi Lollini; Federica Cavallo; Raffaele A Calogero
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.
Cancer immunology, immunotherapy : CII 2005;54(6):599-610.
2005: Elena Quaglino; Cristina Mastini; Manuela Iezzi; Guido Forni; Piero Musiani; Leah N Klapper; Britta Hardy; Federica Cavallo
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice.
Vaccine 2005;23(25):3280-7.
2005: Marco Lo Iacono; Federica Cavallo; Elena Quaglino; Simona Rolla; Manuela Iezzi; Serenella M Pupa; Carla De Giovanni; Pier-Luigi Lollini; Piero Musiani; Guido Forni; Raffaele A Calogero
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.
International journal of immunopathology and pharmacology 2005;18(2):351-63.
2005: Annalisa Astolfi; Lorena Landuzzi; Giordano Nicoletti; Carla De Giovanni; Stefania Croci; Arianna Palladini; Silvano Ferrini; Manuela Iezzi; Piero Musiani; Federica Cavallo; Guido Forni; Patrizia Nanni; Pier-Luigi Lollini
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
The American journal of pathology 2005;166(4):1205-16.
2005: Carmela De Santo; paolo serafini; Ilaria Marigo; Luigi Dolcetti; Manlio Bolla; Piero Del Soldato; Cecilia Melani; Cristiana Guiducci; Mario P Colombo; Manuela Iezzi; Piero Musiani; Paola Zanovello; Vincenzo Bronte
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(11):4185-90.
2005: Michela Spadaro; Elena Ambrosino; Manuela Iezzi; Emma Di Carlo; Pamela Sacchetti; Claudia Curcio; Augusto Amici; Wei-Zen Wei; Piero Musiani; Pier-Luigi Lollini; Federica Cavallo; Guido Forni
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(5):1941-52.
2005: Serenella M Pupa; Manuela Iezzi; Emma Di Carlo; Annamaria Invernizzi; Federica Cavallo; Raffaella Meazza; Alberto Comes; Silvano Ferrini; Piero Musiani; Sylvie Ménard
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.
Cancer research 2005;65(3):1071-8.
2005: Emma Di Carlo; Paola Cappello; Carlo Sorrentino; Tommaso D'Antuono; Antonella Pellicciotta; Mirella Giovarelli; Guido Forni; Piero Musiani; Fréderic Triebel
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway.
The Journal of pathology 2005;205(1):82-91.
2004: Stefania Croci; Giordano Nicoletti; Lorena Landuzzi; Carla De Giovanni; Annalisa Astolfi; Chiara Marini; Emma Di Carlo; Piero Musiani; Guido Forni; Patrizia Nanni; Pier-Luigi Lollini
Immunological prevention of a multigene cancer syndrome.
Cancer research 2004;64(22):8428-34.
2004: Patrizia Nanni; Lorena Landuzzi; Giordano Nicoletti; Carla De Giovanni; Ilaria Rossi; Stefania Croci; Annalisa Astolfi; Manuela Iezzi; Emma Di Carlo; Piero Musiani; Guido Forni; Pier-Luigi Lollini
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(4):2288-96.
2004: Carla De Giovanni; Giordano Nicoletti; Lorena Landuzzi; Annalisa Astolfi; Stefania Croci; Alberto Comes; Silvano Ferrini; Raffaella Meazza; Manuela Iezzi; Emma Di Carlo; Piero Musiani; Federica Cavallo; Patrizia Nanni; Pier-Luigi Lollini
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine.
Cancer research 2004;64(11):4001-9.
2004: Raffaele A Calogero; Piero Musiani; Guido Forni; Federica Cavallo
Towards a long-lasting immune prevention of HER2 mammary carcinomas: directions from transgenic mice.
Cell cycle (Georgetown, Tex.) 2004;3(6):704-6.
2004: Tania Pannellini; Manuela Iezzi; Emma Di Carlo; E Eleuterio; Anna Coletti; Andrea Modesti; S Rosini; MATTEO NERI; Piero Musiani
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis.
International journal of immunopathology and pharmacology 2004;17(2):171-80.
2004: Tonino Alonzi; Ian P Newton; Paul J Bryce; Emma Di Carlo; Giuseppe Lattanzio; Marco Tripodi; Piero Musiani; Valeria Poli
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis.
Cytokine 2004;26(2):45-56.
2004: Elena Quaglino; Manuela Iezzi; Cristina Mastini; Augusto Amici; Federica Pericle; Emma Di Carlo; Serenella M Pupa; Carla De Giovanni; Michela Spadaro; Claudia Curcio; Pier-Luigi Lollini; Piero Musiani; Guido Forni; Federica Cavallo
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.
Cancer research 2004;64(8):2858-64.
2004: Cristiana Guiducci; Emma Di Carlo; Mariella Parenza; Mary Hitt; Mirella Giovarelli; Piero Musiani; Mario P Colombo
Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(7):4026-36.
2004: Elena Quaglino; Simona Rolla; Manuela Iezzi; Michela Spadaro; Piero Musiani; Carla De Giovanni; Pier-Luigi Lollini; Stefania Lanzardo; Guido Forni; Remo Sanges; Stefania Crispi; Pasquale De Luca; Raffaele A Calogero; Federica Cavallo
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.
The Journal of clinical investigation 2004;113(5):709-17.
2004: Emma Di Carlo; Alberto Comes; Anna Maria Orengo; Ombretta Rosso; Raffaella Meazza; Piero Musiani; Mario P Colombo; Silvano Ferrini
IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(3):1540-7.
2004: Tania Pannellini; Guido Forni; Piero Musiani
Immunobiology of her-2/neu transgenic mice.
Breast disease 2004;20():33-42.
2003: Guido Forni; Claudia Curcio; Michela Spadaro; John Iliffe; Elena Quaglino; Emma Di Carlo; Piero Musiani; Pier-Luigi Lollini
Immunization in tumor prevention.
International immunopharmacology 2003;3(8):1151-8.
2003: Anna Maria Orengo; Emma Di Carlo; Alberto Comes; Marina Fabbi; Tiziana Piazza; Michele Cilli; Piero Musiani; Silvano Ferrini
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(2):569-75.
2003: Patrizia Nanni; Giordano Nicoletti; Carla De Giovanni; Lorena Landuzzi; Emma Di Carlo; Manuela Iezzi; Cinzia Ricci; Annalisa Astolfi; Stefania Croci; Francesco Marangoni; Piero Musiani; Guido Forni; Pier-Luigi Lollini
Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.
International journal of cancer. Journal international du cancer 2003;105(3):384-9.
2003: Patrizia Nanni; Giordano Nicoletti; Carla De Giovanni; Stefania Croci; Annalisa Astolfi; Lorena Landuzzi; Emma Di Carlo; Manuela Iezzi; Piero Musiani; Pier-Luigi Lollini
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.
Cancer research 2003;63(11):2728-32.
2003: Paola Cappello; Frederic Triebel; Manuela Iezzi; Cristiana Caorsi; Elena Quaglino; Pier-Luigi Lollini; Augusto Amici; Emma Di Carlo; Piero Musiani; Mirella Giovarelli; Guido Forni
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice.
Cancer research 2003;63(10):2518-25.
2003: Claudia Curcio; Emma Di Carlo; Raphael Clynes; Mark J Smyth; Katia Boggio; Elena Quaglino; Michela Spadaro; Mario P Colombo; Augusto Amici; Pier-Luigi Lollini; Piero Musiani; Guido Forni
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas.
The Journal of clinical investigation 2003;111(8):1161-70.
2003: Giorgia Gri; Elena Gallo; Emma Di Carlo; Piero Musiani; Mario P Colombo
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(1):99-106.
2002: Pier-Luigi Lollini; Carla De Giovanni; Giordano Nicoletti; Emma Di Carlo; Piero Musiani; Patrizia Nanni; Guido Forni
Immunoprevention of colorectal cancer: a future possibility?
Gastroenterology clinics of North America 2002;31(4):1001-14.
2002: Mauro Brunetti; Nicola Mascetra; Nicola Martelli; Franco O Ranelletti; Piero Musiani; Francesca B Aiello
Synergistic inhibitory activities of interleukin-10 and dexamethasone on human CD4+ T cells.
Transplantation 2002;74(8):1152-8.
2002: Mauro Brunetti; Nicola Mascetra; Stefano Manarini; Nicola Martelli; Chiara Cerletti; Piero Musiani; Francesca B Aiello; Virgilio Evangelista
Inhibition of cGMP-dependent protein kinases potently decreases neutrophil spontaneous apoptosis.
Biochemical and biophysical research communications 2002;297(3):498-501.
2002: Alberto Comes; Emma Di Carlo; Piero Musiani; Ombretta Rosso; Raffaella Meazza; Claudia Chiodoni; Mario P Colombo; Silvano Ferrini
IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
European journal of immunology 2002;32(7):1914-23.
2002: Elena Quaglino; Stefania Rovero; Federica Cavallo; Piero Musiani; Augusto Amici; Giordano Nicoletti; Patrizia Nanni; Guido Forni
Immunological prevention of spontaneous tumors: a new prospect?
Immunology letters 2002;80(2):75-9.
2001: Emma Di Carlo; Manuela Iezzi; Tania Pannellini; F Zaccardi; Andrea Modesti; Guido Forni; Piero Musiani
Neutrophils in anti-cancer immunological strategies: old players in new games.
Journal of hematotherapy & stem cell research 2001;10(6):739-48.
2001: Patrizia Nanni; Giordano Nicoletti; Carla De Giovanni; Lorena Landuzzi; Emma Di Carlo; Federica Cavallo; Serenella M Pupa; Ilaria Rossi; Mario P Colombo; Cinzia Ricci; Annalisa Astolfi; Piero Musiani; Guido Forni; Pier-Luigi Lollini
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice.
The Journal of experimental medicine 2001;194(9):1195-205.
2001: Carla De Giovanni; Giordano Nicoletti; Lorena Landuzzi; Ilaria Rossi; Annalisa Astolfi; Cinzia Ricci; E Di Carlo; Piero Musiani; Guido Forni; D Fradelizi; Patrizia Nanni; Pier-Luigi Lollini
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gamma.
Gene therapy 2001;8(22):1698-704.
2001: Claudia Colussi; S Fiumicino; alessandro Giuliani; S Rosini; Piero Musiani; C Macrí; C S Potten; Marco Crescenzi; Margherita Bignami
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.
Journal of the National Cancer Institute 2001;93(20):1534-40.
2001: F Gavallo; E Di Carlo; E Quaglin; M Jezzi; Marina Strasly; Federico Bussolino; Mario P Colombo; Patrizia Nanni; Pier-Luigi Lollini; Piero Musiani; Guido Forni
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice.
Journal of biological regulators and homeostatic agents 2001;15(4):351-8.
2001: Tonino Alonzi; G Middleton; Sean Wyatt; Vladimir L Buchman; Werner Muller; W Müller; Piero Musiani; Valeria Poli; Alun M Davies
Role of STAT3 and PI 3-kinase/Akt in mediating the survival actions of cytokines on sensory neurons.
Molecular and cellular neurosciences 2001;18(3):270-82.
2001: Federica Cavallo; Elena Quaglino; L Cifaldi; Emma Di Carlo; A André; Paola Bernabei; Piero Musiani; Guido Forni; Raffaele A Calogero
Interleukin 12-activated lymphocytes influence tumor genetic programs.
Cancer research 2001;61(8):3518-23.
2001: L Cifaldi; Elena Quaglino; Emma Di Carlo; Piero Musiani; Michela Spadaro; Pier-Luigi Lollini; Stanley Wolf; Katia Boggio; Guido Forni; Federica Cavallo
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia.
Cancer research 2001;61(7):2809-12.
2001: Stefania Rovero; Katia Boggio; E Di Carlo; Augusto Amici; Elena Quaglino; Paola Porcedda; Piero Musiani; Guido Forni
Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice.
Gene therapy 2001;8(6):447-52.
2001: Emma Di Carlo; Stefania Rovero; Katia Boggio; Elena Quaglino; Augusto Amici; Arianna Smorlesi; Guido Forni; Piero Musiani
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):830s-837s.
2001: Emma Di Carlo; Guido Forni; P Lollini; M P Colombo; Andrea Modesti; Piero Musiani
The intriguing role of polymorphonuclear neutrophils in antitumor reactions.
Blood 2001;97(2):339-45.
2001: Serenella M Pupa; Annamaria Invernizzi; Stefania Forti; Emma Di Carlo; Piero Musiani; Patrizia Nanni; Pier-Luigi Lollini; Raffaella Meazza; Silvano Ferrini; Sylvie Menard
Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.
Gene therapy 2001;8(1):75-9.
2000: MG Diodoro; Emma Di Carlo; R Zappacosta; Manuela Iezzi; Anna Coletti; Andrea Modesti; Tommaso D'Antuono; Guido Forni; Piero Musiani
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression.
International journal of cancer. Journal international du cancer 2000;88(3):329-35.
2000: Stefania Rovero; Augusto Amici; E Di Carlo; Roberto Bei; Patrizia Nanni; Elena Quaglino; Paola Porcedda; Katia Boggio; Arianna Smorlesi; Pier-Luigi Lollini; Lorena Landuzzi; Mario P Colombo; Mirella Giovarelli; Piero Musiani; Guido Forni
DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(9):5133-42.
2000: Emma Di Carlo; Alberto Comes; S Basso; Alessandro De Ambrosis; Raffaella Meazza; Piero Musiani; K Moelling; A Albini; Silvano Ferrini
The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(6):3111-8.
2000: Alessia Gaggero; Alberto Comes; Raffaella Meazza; Emma Di Carlo; Piero Musiani; Bruno Azzarone; Silvano Ferrini
Different biological role and anti-tumor activity of interleukin-15 isoforms.
European cytokine network 2000;11(3):517-8.
2000: Mauro Brunetti; Nicola Martelli; Stefano Manarini; Nicola Mascetra; Piero Musiani; Chiara Cerletti; Francesca B Aiello; Virgilio Evangelista
Polymorphonuclear leukocyte apoptosis is inhibited by platelet-released mediators, role of TGFbeta-1.
Thrombosis and haemostasis 2000;84(3):478-83.
2000: Raffaella Meazza; Pier-Luigi Lollini; Patrizia Nanni; Carla De Giovanni; Alessia Gaggero; Alberto Comes; Michele Cilli; Emma Di Carlo; Silvano Ferrini; Piero Musiani
Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response.
International journal of cancer. Journal international du cancer 2000;87(4):574-81.
2000: Patrizia Nanni; Serenella M Pupa; Giordano Nicoletti; Carla De Giovanni; Lorena Landuzzi; Ilaria Rossi; Annalisa Astolfi; Cinzia Ricci; R De Vecchi; Annamaria Invernizzi; Emma Di Carlo; Piero Musiani; Guido Forni; S Menard; Pier-Luigi Lollini
p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma.
International journal of cancer. Journal international du cancer 2000;87(2):186-94.
2000: Emma Di Carlo; Raffaella Meazza; S Basso; Ombretta Rosso; Alberto Comes; Alessia Gaggero; Piero Musiani; L Santi; Silvano Ferrini
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice.
The Journal of pathology 2000;191(2):193-201.
2000: Guido Forni; Pier-Luigi Lollini; Piero Musiani; Mario P Colombo
Immunoprevention of cancer: is the time ripe?
Cancer research 2000;60(10):2571-5.
2000: Mirella Giovarelli; Paola Cappello; Guido Forni; TW Salcedo; Paul Moore; D W LeFleur; Bernardetta Nardelli; E Di Carlo; Pier-Luigi Lollini; Steve Ruben; Stephen Ullrich; G Garotta; Piero Musiani
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(6):3200-6.
2000: Katia Boggio; Emma Di Carlo; Stefania Rovero; Federica Cavallo; Elena Quaglino; Pier-Luigi Lollini; Patrizia Nanni; Giordano Nicoletti; Stanley Wolf; Piero Musiani; Guido Forni
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.
Cancer research 2000;60(2):359-64.
1999: Mirella Giovarelli; Piero Musiani; G Garotta; R Ebner; Emma Di Carlo; Y Kim; Paola Cappello; Laura Rigamonti; Paola Bernabei; Francesco Novelli; Andrea Modesti; Anna Coletti; A K Ferrie; Pier-Luigi Lollini; Steve Ruben; TW Salcedo; Guido Forni
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(9):4886-93.
1999: Emma Di Carlo; MG Diodoro; Katia Boggio; Andrea Modesti; M Modesti; Patrizia Nanni; Guido Forni; Piero Musiani
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin.
Laboratory investigation; a journal of technical methods and pathology 1999;79(10):1261-9.
1999: Carmela Rozera; Davide Carlei; Pier-Luigi Lollini; Carla De Giovanni; Piero Musiani; E Di Carlo; Filippo Belardelli; Maria Ferrantini
Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response.
The American journal of pathology 1999;154(4):1211-22.
1999: Federica Cavallo; Emma Di Carlo; M Butera; R Verrua; Mario P Colombo; Piero Musiani; Guido Forni
Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12.
Cancer research 1999;59(2):414-21.
1998: Emma Di Carlo; Andrea Modesti; Anna Coletti; Mario P Colombo; Mirella Giovarelli; Guido Forni; MG Diodoro; Piero Musiani
Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour.
The Journal of pathology 1998;186(4):390-7.
1998: Pier-Luigi Lollini; Giordano Nicoletti; Lorena Landuzzi; Carla De Giovanni; Ilaria Rossi; Emma Di Carlo; Piero Musiani; W J Muller; Patrizia Nanni
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice.
International journal of cancer. Journal international du cancer 1998;77(6):937-41.
1998: Katia Boggio; Giordano Nicoletti; Emma Di Carlo; Federica Cavallo; Lorena Landuzzi; Cecilia Melani; Mirella Giovarelli; Ilaria Rossi; Patrizia Nanni; Carla De Giovanni; P Bouchard; Stanley Wolf; Andrea Modesti; Piero Musiani; Pier-Luigi Lollini; Mario P Colombo; Guido Forni
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.
The Journal of experimental medicine 1998;188(3):589-96.
1998: Mauro Brunetti; Antonella Colasante; Nicola Mascetra; Mauro Piantelli; Piero Musiani; Francesca B Aiello
IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation.
The Journal of pharmacology and experimental therapeutics 1998;285(2):915-9.
1998: Emma Di Carlo; Anna Coletti; Andrea Modesti; Mirella Giovarelli; Guido Forni; Piero Musiani
Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection.
European cytokine network 1998;9(1):61-8.
1998: Ilaria Rossi; Giordano Nicoletti; Lorena Landuzzi; Flavia Frabetti; Carla De Giovanni; Patrizia Nanni; Piero Musiani; Maria Ferrantini; F Belardelli; Pier-Luigi Lollini
Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene-transduced tumor cells.
Clinical & experimental metastasis 1998;16(2):123-8.
1998: Patrizia Nanni; Carla De Giovanni; Giordano Nicoletti; Lorena Landuzzi; Ilaria Rossi; Flavia Frabetti; Mirella Giovarelli; Guido Forni; Federica Cavallo; Emma Di Carlo; Piero Musiani; Pier-Luigi Lollini
The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cells.
Human gene therapy 1998;9(2):217-24.
1998: Maria Valeria Corrias; S Basso; Raffaella Meazza; Piero Musiani; L Santi; Paola Bocca; Marzia Occhino; Silvano Ferrini; Vito Pistoia
Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene.
Cancer gene therapy 1998;5(1):38-44.
1997: Laura Santodonato; Giuseppina D'Agostino; Stefano M Santini; Davide Carlei; Piero Musiani; Andrea Modesti; P Signorelli; Filippo Belardelli; Maria Ferrantini
Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.
Gene therapy 1997;4(11):1246-55.
1997: Antonella Colasante; Nicola Mascetra; Mauro Brunetti; Giuseppe Lattanzio; MG Diodoro; S Caltagirone; Piero Musiani; Francesca B Aiello
Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors.
American journal of respiratory and critical care medicine 1997;156(3 Pt 1):968-73.
1997: Giuseppe Lattanzio; C Libert; M Aquilina; Manuela Cappelletti; Gennaro Ciliberto; Piero Musiani; V Poli
Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.
The American journal of pathology 1997;151(3):689-96.
1997: Federica Cavallo; P Signorelli; Mirella Giovarelli; Piero Musiani; A Modesti; M J Brunda; Mario P Colombo; Guido Forni
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.
Journal of the National Cancer Institute 1997;89(14):1049-58.
1997: S Caltagirone; Franco O Ranelletti; Alessandro Rinelli; Nicola Maggiano; Antonella Colasante; Piero Musiani; Francesca B Aiello; Mauro Piantelli
Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer.
American journal of respiratory cell and molecular biology 1997;17(1):51-9.
1997: Emma Di Carlo; Andrea Modesti; Graziella Castrilli; Lorena Landuzzi; A Allione; C de Giovanni; T Musso; Piero Musiani
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential.
The Journal of pathology 1997;182(1):76-85.
1997: Susanna Scarpa; Anna Giuffrida; Camilla Palumbo; Fortunata Vasaturo; P Signorelli; Guido Forni; Mauro Modesti; Maria Ferrantini; Filippo Belardelli; Piero Musiani; Andrea Modesti
Extracellular matrix remodelling in a murine mammary adenocarcinoma transfected with the interferon-alpha 1 gene.
The Journal of pathology 1997;181(1):116-23.
1997: Graziella Castrilli; D Tatone; MG Diodoro; S Rosini; Mauro Piantelli; Piero Musiani
Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells.
British journal of cancer 1997;75(6):855-9.
1997: Piero Musiani; Andrea Modesti; Mirella Giovarelli; Federica Cavallo; Mario P Colombo; Pier-Luigi Lollini; Guido Forni
Cytokines, tumour-cell death and immunogenicity: a question of choice.
Immunology today 1997;18(1):32-6.
1996: Isabella Screpanti; Piero Musiani; Diana Bellavia; Manuela Cappelletti; F B Aiello; Marella Maroder; Luigi Frati; Andrea Modesti; Alberto Gulino; Valeria Poli
Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice.
The Journal of experimental medicine 1996;184(4):1561-6.
1996: Venerino Poletti; Graziella Castrilli; M Romagna; Antonella Colasante; Francesca B Aiello; Giuseppe Baruzzi; Piero Musiani
Bronchoalveolar lavage, histological and immunohistochemical features in cryptogenic organizing pneumonia.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 1996;51(4):289-95.
1996: S Rosini; S Caltagirone; G Tallini; G Lattanzio; R Demopoulos; Mauro Piantelli; Piero Musiani
Depletion of stromal and intraepithelial antigen-presenting cells in cervical neoplasia in human immunodeficiency virus infection.
Human pathology 1996;27(8):834-8.
1996: Laura Santodonato; Maria Ferrantini; L Gabriele; Enrico Proietti; Massimo Venditti; Piero Musiani; Andrea Modesti; Anna Modica; S D Lupton; Filippo Belardelli
Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.
Human gene therapy 1996;7(1):1-10.
1996: Piero Musiani; Attilio Allione; Anna Modica; P L Lollini; M Giovarelli; Federica Cavallo; Filippo Belardelli; Guido Forni; Andrea Modesti
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
Laboratory investigation; a journal of technical methods and pathology 1996;74(1):146-57.
1995: Elena Fattori; Lazzaro Domenico; Piero Musiani; Andrea Modesti; Tonino Alonzi; Gennaro Ciliberto
IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage.
The European journal of neuroscience 1995;7(12):2441-9.
1995: Mauro Brunetti; N Martelli; Antonella Colasante; Mauro Piantelli; Piero Musiani; Francesca B Aiello
Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes.
Blood 1995;86(11):4199-205.
1995: Mirella Giovarelli; Piero Musiani; Andrea Modesti; Paolo Dellabona; Giulia Casorati; Attilio Allione; M Consalvo; Federica Cavallo; F di Pierro; C De Giovanni
Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(6):3112-23.
1995: Antonella Colasante; Graziella Castrilli; Francesca B Aiello; Mauro Brunetti; Piero Musiani
Role of cytokines in distribution and differentiation of dendritic cell/Langerhans' cell lineage in human primary carcinomas of the lung.
Human pathology 1995;26(8):866-72.
1995: M Consalvo; Craig A Mullen; Andrea Modesti; Piero Musiani; Attilio Allione; Federica Cavallo; Mirella Giovarelli; Guido Forni
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(10):5302-12.
1995: Isabella Screpanti; L Romani; Piero Musiani; Andrea Modesti; Elena Fattori; Lazzaro Domenico; C Sellitto; Susanna Scarpa; Diana Bellavia; G Lattanzio
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice.
The EMBO journal 1995;14(9):1932-41.
1994: F Pericle; Mirella Giovarelli; Mario P Colombo; G Ferrari; Piero Musiani; Andrea Modesti; Federica Cavallo; F Di Pierro; Francesco Novelli; Guido Forni
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(12):5659-73.
1994: Maria Ferrantini; Mirella Giovarelli; Andrea Modesti; Piero Musiani; Anna Modica; Massimo Venditti; E Peretti; Pier-Luigi Lollini; Patrizia Nanni; Guido Forni
IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(10):4604-15.
1994: C M Ausiello; Paola Sestili; C Locardi; Mariantonia Logozzi; Paola Rizza; Eleonora Parlanti; L Yang; Anna Modica; Andrea Modesti; Piero Musiani
Defective response to T cell mitogens in mice injected with human immunodeficiency virus type 1-infected U937 cells.
The Journal of general virology 1994;75 ( Pt 10)():2789-94.
1994: Piero Musiani; Andrea Modesti; M Brunetti; Anna Modica; P Vitullo; A Gulino; M C Bosco; M P Colombo; Patrizia Nanni; Federica Cavallo
Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes.
Natural immunity 1994;13(2-3):93-101.
1993: Guido Forni; Mirella Giovarelli; Federica Cavallo; M Consalvo; Attilio Allione; Andrea Modesti; Piero Musiani; Mario P Colombo
Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapy.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(4):253-7.
1993: Pier-Luigi Lollini; M C Bosco; Federica Cavallo; Carla De Giovanni; Mirella Giovarelli; Lorena Landuzzi; Piero Musiani; Andrea Modesti; Giordano Nicoletti; G Palmieri
Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene.
International journal of cancer. Journal international du cancer 1993;55(2):320-9.
1993: Antonella Colasante; Venerino Poletti; S Rosini; R Ferracini; Piero Musiani
Langerhans cells in Langerhans cell histiocytosis and peripheral adenocarcinomas of the lung.
The American review of respiratory disease 1993;148(3):752-9.
1992: Antonella Colasante; S Rosini; A Piattelli; L Artese; Francesca B Aiello; Piero Musiani
Distribution and phenotype of immune cells in normal human gingiva: active immune response versus unresponsiveness.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1992;21(1):12-6.
1991: D Angelucci; P G Natali; Amerio Paolo; M Ramenghi; Piero Musiani
Rapid perinatal growth mimicking malignant transformation in a giant congenital melanocytic nevus.
Human pathology 1991;22(3):297-301.
1991: A Piattelli; L Artese; S Rosini; M Quaranta; Piero Musiani
Immune cells in periapical granuloma: morphological and immunohistochemical characterization.
Journal of endodontics 1991;17(1):26-9.
1987: F O Ranelletti; N Maggiano; Francesca B Aiello; A Carbone; L M Larocca; Piero Musiani; Mauro Piantelli
Glucocorticoid receptors and corticosensitivity of human thymocytes at discrete stages of intrathymic differentiation.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(2):440-5.
1986: Mauro Piantelli; L M Larocca; Francesca B Aiello; N Maggiano; A Carbone; F O Ranelletti; Piero Musiani
Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptors.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(9):3204-10.
1986: F O Ranelletti; Mauro Piantelli; A Carbone; N Maggiano; L M Larocca; Francesca B Aiello; Piero Musiani
The mature, mitogen-responsive, human thymocyte population comprises two functionally distinct T-cell subsets differing in exogenous interleukin requirements for mitogenesis and in sensitivity to glucocorticoids.
Scandinavian journal of immunology 1986;23(4):407-14.
1986: Francesca B Aiello; N Maggiano; L M Larocca; Mauro Piantelli; Piero Musiani
Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation.
Cellular immunology 1986;97(1):131-9.
1985: Francesca B Aiello; Piero Musiani; N Maggiano; L M Larocca; Mauro Piantelli
T3 expression by human thymocytes in culture.
Clinical and experimental immunology 1985;61(2):433-9.
1985: Piero Musiani; Francesca B Aiello; F Citterio; N Maggiano; L M Larocca; Mauro Piantelli
Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients.
Clinical and experimental immunology 1985;61(1):152-9.
1985: Piero Musiani; N Maggiano; Francesca B Aiello; A Carbone; F O Ranelletti; Mauro Piantelli
Proliferative capabilities of T3-positive thymocytes.
Cellular immunology 1985;90(2):358-65.
1984: Piero Musiani; N Maggiano; Francesca B Aiello; L Lauriola; F O Ranelletti; Mauro Piantelli
Ia- and IgG-Fc receptor-positive accessory cell sustains peripheral T lymphocyte but not thymocyte mitogenesis induced by OKT3 monoclonal antibody.
Cellular immunology 1984;84(2):333-40.
1984: Piero Musiani; F Citterio; N Maggiano; U Pozzetto; L Lauriola; G Luciani; F O Ranelletti; Marco Castagneto; Mauro Piantelli
Glucocorticoid inhibitory action on the response to PHA of residual circulatory lymphocytes in renal transplant patients following immunosuppressive therapy.
Clinical and experimental immunology 1984;55(1):217-23.
1981: G Luciani; N Maggiano; F Citterio; L Lauriola; U Pozzetto; Mauro Piantelli; Marco Castagneto; Piero Musiani
Imbalances in peripheral blood T-cell subpopulations in renal transplant patients.
Clinical and experimental immunology 1981;46(3):615-20.